Table 1.
Comparison of baseline data between the two groups (x̅ ± sd)/[n (%)]
| Data | Observation group (n=45) | Control group (n=44) | t/X2 | P | |
|---|---|---|---|---|---|
| Gender | Male | 26 (57.78) | 28 (63.64) | 0.320 | 0.572 |
| Female | 19 (42.22) | 16 (36.36) | |||
| Age (years) | 68.75±11.43 | 67.52±10.19 | 0.535 | 0.594 | |
| Duration of Parkinson’s disease (years) | 5.62±2.75 | 5.81±2.83 | 0.321 | 0.749 | |
| Duration of depressive symptoms (months) | 5.32±0.59 | 5.41±0.62 | 0.702 | 0.485 | |
| BMI (kg/m2) | 22.34±1.19 | 21.98±1.05 | 1.512 | 0.134 | |
| Levodopa equivalent daily dose | 581.36±152.16 | 569.45±147.21 | 0.375 | 0.708 | |
| Hoehn-yahrrating (points) | 3.16±1.86 | 3.22±1.69 | 0.159 | 0.874 | |